Ovid Therapeutics Inc (OVID) financials · $23.5M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Ovid Therapeutics Inc (OVID) $23.5M cap.
| Line | Q2 2026 | Q1 2026 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Revenue | $733.00K | — | |
| Operating Income | −$15.70M | −$17.85M | |
| Net Income | −$15.01M | −$16.99M | |
| Unlock the full statement history: Lician Pro $149/yr | |||
| Line | Q2 2026 | Q1 2026 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $231.97M | $225.63M | |
| Current Assets | $123.62M | $160.15M | |
| Cash & Equivalents | $11.33M | $94.06M | |
| PP&E | $201.00K | $217.00K | |
| Total Liabilities | $22.08M | $27.36M | |
| Current Liabilities | $9.98M | $15.75M | |
| Shareholders' Equity | $209.89M | $198.27M | |
| Retained Earnings | −$353.71M | −$338.70M |
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$38.33M | −$55.96M | |
| CapEx | — | $71.00K | |
| Investing Cash Flow | −$49.85M | $54.59M | |
| Financing Cash Flow | $75.21M | $622.00K | |
| Net Change in Cash | −$13.15M | −$740.00K | |
| Free Cash Flow | −$38.33M | −$56.03M |
Source: Company filings with the SEC (EDGAR) · Latest period Q2 2026
FAQ
What is OVID P/E and revenue?
Ovid Therapeutics Inc (OVID) $23.5M cap.
What is OVID revenue?
Ovid Therapeutics Inc last cached revenue is $733.0K (Q2 2026).
Is OVID profitable?
Ovid Therapeutics Inc last cached net income is -$15.0M (Q2 2026).
What are OVID total assets?
Ovid Therapeutics Inc last cached total assets are $232.0M (Q2 2026).
What is OVID free cash flow?
Ovid Therapeutics Inc last cached free cash flow is -$38.3M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.